Supporting Evidence

Despite high vaccine coverage and the simultaneous occurrence of ever emerging variants, the CDC continues to claim that it is a “myth” that “COVID-19 vaccines cause variants.”

Early on in the pandemic, the media warned the public people could potentially catch Covid-19 twice and our federal health agencies assured the public they were closely monitoring for potential reinfections.

The v-safe protocol lists a series of 15 “Adverse Events of Special Interest” but, unbelievably, the v-safe program itself does not even track these adverse events!

For the second time, the FDA has avoided answering very simple questions about discrepancies concerning the numbers of deaths in Pfizer’s clinical trial, citing “resource constraints” and blaming its workload, in part, on ICAN’s FOIA requests.

As the result of FOIA requests, ICAN is the first to exclusively receive lot, dose, and distribution information on Pfizer’s Covid-19 vaccine, which may finally make it possible to perform certain crucial scientific analysis on the safety profile of this product.

ICAN has filed a Citizen Petition with the FDA calling on the agency to reverse its reckless course on Covid-19 injections for teenagers. The Petition demands that the FDA revoke its emergency use authorization (EUA) for Pfizer’s product in children aged 12 through 15 and deny Moderna any future EUA for children aged 12 through 17.

Recently, we told you that vaccine manufacturers have to submit FOIA requests to the FDA to obtain additional information regarding serious adverse events, including deaths, following the use of their products that are submitted to VAERS. We know this because Janssen’s Chief Medical Officer (CMO) said so during his presentation at the CDC’s Advisory Committee on Immunization Practices (ACIP) meeting, convened to investigate the safety of the J&J/Janssen vaccine.

Vaccine manufacturers, like the rest of the public, must submit a FOIA to the FDA to obtain additional information regarding serious adverse events, including deaths, submitted to VAERS. The problem: they are not doing it.

ICAN attorneys and research staff watch every meeting of the FDA’s VRBPAC and the CDC’s ACIP. What is seen over the course of many meetings are the patterns and methods by which these agencies rig the approval process to achieve pre-determined outcomes. Now VRBPAC and ACIP are gearing up to pre-approve all future COVID-19 shots, regardless of formulation, with no additional clinical trials!

FDA Assigned Pfizer’s COVID Vaccine a License Number Months Prior to Actually Licensing It

On December 16, 2020, ICAN submitted a Freedom of Information Act (FOIA) request to the Centers for Disease Control and Prevention (CDC) which resulted in the production of an email showing the cozy relationship between Pfizer and the CDC official now heading up its COVID-19 Vaccine Task Force.

The JCVI has advised that pregnant women should be offered the COVID-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group.

AstraZeneca study finds vector DNA in the sciatic nerve, bone marrow, liver, lungs, and spleen of vaccinated mice.

In light of the startling increase in reports of reproductive issues following vaccination, ICAN’s attorneys recently wrote a letter to our federal health agencies demanding to know why Americans were not given the same strict instructions regarding COVID-19 vaccines and reproduction that Pfizer gave its clinical trial participants.

ICAN’s attorneys reviewed a startling report from June 2020 that Pfizer submitted to the FDA concerning its mRNA COVID-19 vaccine.

ICAN has repeatedly demanded that CDC and other “health” agencies appropriately attribute deaths from COVID vs deaths with COVID.

A Federal judge ordered FDA to release the documents it relied upon to license Pfizer and Moderna COVID-19 Vaccines for 12-15 yr-olds.

ICAN uncovers that the FDA deviated from long-standing protocols concerning vaccine safety for COVID-19 Vaccines.

NASEM met to review literature on adverse reactions to COVID-19 vaccines and it is expected to release a report based upon that review soon.

The latest batch of Pfizer COVID-19 Vaccine documents contain case report forms of 212 trial subjects, and many are highly concerning.

After members of Congress sent an urgent letter to VRBPAC, FDA’s vaccine advisory committee, raising critical questions regarding the safety of COVID-19 vaccines for infants and children, ICAN’s attorneys submitted FOIA requests which revealed that none of the lead members of VRBPAC bothered to even discuss the letter, let alone reply to Congress. On June […]

ICAN discovered 1,102 deleted reports from the Vaccine Adverse Event Reporting System(VAERS). ICAN wrote CDC, FDA, and HHS demanding answers.

In July, ICAN uncovered highly concerning case report forms from individuals in Pfizer’s clinical trial. The August batch contains even more.

ICAN-obtained presentation indicates CDC, FDA and NIH higher-ups knew about shocking levels of waning immunity and breakthrough infection.

The September batch of COVID vaccine trial documents covers a range of information, inc. interesting correspondence between FDA and Pfizer

In May 2021, CDC knew over 50% of fully vaccinated assisted living residents in a California facility were suffering breakthrough infections

FDA says it has produced all documents in the biologic product file of Pfizer’s COVID-19 vaccine for ages 16 and up, 800 days after approval.

ICAN asked the CDC to produce its data that support the efficacy of COVID-19 boosters for 12-49 year olds. The response? Shocking.

ICAN has obtained unreleased lot and dose data for the Moderna and Pfizer COVID-19 vaccines. OpenVAERS’ analyses of this data indicates several “hot lots.”

A federal judge has ordered the CDC to release all 7.8 million v-safe free text field entries over the next 12 months.